Cargando…
Healthcare disparities among anticoagulation therapies for severe COVID‐19 patients in the multi‐site VIRUS registry
Here we analyze hospitalized andintensive care unit coronavirus disease 2019 (COVID‐19) patient outcomes from the international VIRUS registry (https://clinicaltrials.gov/ct2/show/NCT04323787). We find that COVID‐19 patients administered unfractionated heparin but not enoxaparin have a higher mortal...
Autores principales: | Kirkup, Christian, Pawlowski, Colin, Puranik, Arjun, Conrad, Ian, O'Horo, John C., Gomaa, Dina, Banner‐Goodspeed, Valerie M, Mosier, Jarrod M, Zabolotskikh, Igor Borisovich, Daugherty, Steven K., Bernstein, Michael A., Zaren, Howard A., Bansal, Vikas, Pickering, Brian, Badley, Andrew D., Kashyap, Rahul, Venkatakrishnan, A. J., Soundararajan, Venky |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013987/ https://www.ncbi.nlm.nih.gov/pubmed/33666246 http://dx.doi.org/10.1002/jmv.26918 |
Ejemplares similares
-
Enoxaparin is associated with lower rates of mortality than unfractionated Heparin in hospitalized COVID-19 patients
por: Pawlowski, Colin, et al.
Publicado: (2021) -
Pre-existing conditions are associated with COVID-19 patients’ hospitalization, despite confirmed clearance of SARS-CoV-2 virus
por: Pawlowski, Colin, et al.
Publicado: (2021) -
Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations
por: Pawlowski, Colin, et al.
Publicado: (2021) -
FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system
por: Pawlowski, Colin, et al.
Publicado: (2021) -
Mapping each pre-existing condition’s association to short-term and long-term COVID-19 complications
por: Venkatakrishnan, A. J., et al.
Publicado: (2021)